HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (93) Citing Articles via Google Scholar Google Scholar Articles by Antó, J.M. Articles by Sunyer, J. Search for Related Content PubMed PubMed Citation Articles by Antó, J.M. Articles by Sunyer, J.

Epidemiology of chronic obstructive pulmonary disease

¹ Respiratory and Environmental Health Research Unit, Institut Municipal d'Investigació Mèdica (IMIM), Barcelona, Spain, ² Dept of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, Spain, ³ Dept of Pulmonary Medicine, University of Antwerp (UIA), Antwerp-Wilrijk, Belgium and ⁴ Dept of Respiratory Medicine, Hvidovre University Hospital, Denmark

CORRESPONDENCE: J.M. Antó, Respiratory and Environmental Health Research Unit, Institut Municipal d'Investigació Mèdica (IMIM), Carrer del Doctor Aiguader, 80, E-08003-Barcelona, Spain. Fax: 34 932213237

Keywords: -1-antitrypsin deficiency, chronic obstructive pulmonary disease, epidemiology, passive smoking, smoking

Received: February 8, 2001
Accepted February 22, 2001

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of world-wide mortality and disability. On average 5–15% of adults in industrialized countries have COPD defined by spirometry. In 1990, COPD was considered to be at the twelfth position world-wide as a cause of combined mortality and disability but is expected to become the fifth cause by the year 2020.

COPD has a chronic long-lasting course characterized by irreversible decline of forced expiratory volume in one second (FEV₁), increasing presence of dyspnoea and other respiratory symptoms, and progressive deterioration of health status. After diagnosis the 10-yr survival rate is 50% with more than one-third of patients dying due to respiratory insufficiency.

Several environmental exposures such as air pollution increase the risk of death in COPD patients. The aetiology of COPD is overwhelmingly dominated by smoking although many other factors could play a role. Particular genetic variants are likely to increase the susceptibility to environmental factors although little is known about which are the relevant genes. There is clear evidence about the role of the -1-antitrypsin but the fraction of COPD attributable to the relevant variants is only 1%. Phenotypic traits that are considered to play a role in the development of COPD include sex, with females being at a higher risk, bronchial responsiveness and atopy. There is strong causal evidence regarding the relationship between smoking and COPD with decline in FEV₁ levelling off after smoking cessation. Passive smoking has been found to be associated with a small though statistically significant decline in FEV₁. Other risk factors that are likely to be relevant in the development of COPD are occupation, low socioeconomic status, diet and possibly some environmental exposures in early life.

Although there is accumulating evidence that oxygen therapy, pharmacological treatment and rehabilitation may improve the course of chronic obstructive pulmonary disease, preventing smoking continues to be the most relevant measure, not only to prevent chronic obstructive pulmonary disease, but also to arrest its development.

This article has been cited by other articles:

				M Siedlinski, C C van Diemen, D S Postma, and H M Boezen Heme oxygenase 1 variations and lung function decline in smokers: proof of replication J. Med. Genet., June 1, 2008; 45(6): 400 - 400. [Full Text] [PDF]

				O. A. Minai, J. Benditt, and F. J. Martinez Natural History of Emphysema Proceedings of the ATS, May 1, 2008; 5(4): 468 - 474. [Abstract] [Full Text] [PDF]

				A. Caballero, C. A. Torres-Duque, C. Jaramillo, F. Bolivar, F. Sanabria, P. Osorio, C. Orduz, D. P. Guevara, and D. Maldonado Prevalence of COPD in Five Colombian Cities Situated at Low, Medium, and High Altitude (PREPOCOL Study) Chest, February 1, 2008; 133(2): 343 - 349. [Abstract] [Full Text] [PDF]

				P. Harber, D. P. Tashkin, M. Simmons, L. Crawford, E. Hnizdo, J. Connett, and for the Lung Health Study Group Effect of Occupational Exposures on Decline of Lung Function in Early Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 15, 2007; 176(10): 994 - 1000. [Abstract] [Full Text] [PDF]

				M. J. Hegewald and R. O. Crapo Socioeconomic Status and Lung Function Chest, November 1, 2007; 132(5): 1608 - 1614. [Abstract] [Full Text] [PDF]

				F. Holguin Traffic related exposures and lung function in adults Thorax, October 1, 2007; 62(10): 837 - 838. [Full Text] [PDF]

				C. Scully and R. L. Ettinger The Influence of Systemic Diseases on Oral Health Care in Older Adults J Am Dent Assoc, September 1, 2007; 138(suppl_1): 7S - 14S. [Abstract] [Full Text] [PDF]

				M. A. Kolodziej, L. Jensen, B. Rowe, and D. Sin Systematic review of noninvasive positive pressure ventilation in severe stable COPD Eur. Respir. J., August 1, 2007; 30(2): 293 - 306. [Abstract] [Full Text] [PDF]

				R. de Marco, S. Accordini, I. Cerveri, A. Corsico, J. M. Anto, N. Kunzli, C. Janson, J. Sunyer, D. Jarvis, S. Chinn, et al. Incidence of Chronic Obstructive Pulmonary Disease in a Cohort of Young Adults According to the Presence of Chronic Cough and Phlegm Am. J. Respir. Crit. Care Med., January 1, 2007; 175(1): 32 - 39. [Abstract] [Full Text] [PDF]

				B. Hauns, R. Hermann, A. Hunnemeyer, R. Herzog, D. Hauschke, K. Zech, and T. D. Bethke Investigation of a potential food effect on the pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, in healthy subjects. J. Clin. Pharmacol., October 1, 2006; 46(10): 1146 - 1153. [Abstract] [Full Text] [PDF]

				T M L Eagan, J Hetland, and L E Aaro Decline in respiratory symptoms in service workers five months after a public smoking ban Tob. Control, June 1, 2006; 15(3): 242 - 246. [Abstract] [Full Text] [PDF]

				G. Devereux Definition, epidemiology, and risk factors. BMJ, May 13, 2006; 332(7550): 1142 - 1144. [Full Text] [PDF]

				M. Tsoumakidou, E. Papadopouli, N. Tzanakis, and N. M. Siafakas Airway Inflammation and Cellular Stress in Noneosinophilic Atopic Asthma Chest, May 1, 2006; 129(5): 1194 - 1202. [Abstract] [Full Text] [PDF]

				Y Hu, B Chen, Z Yin, L Jia, Y Zhou, and T Jin Increased risk of chronic obstructive pulmonary diseases in coke oven workers: interaction between occupational exposure and smoking Thorax, April 1, 2006; 61(4): 290 - 295. [Abstract] [Full Text] [PDF]

				D. M. Mannino, G. Watt, D. Hole, C. Gillis, C. Hart, A. McConnachie, G. Davey Smith, M. Upton, V. Hawthorne, D. D. Sin, et al. The natural history of chronic obstructive pulmonary disease. Eur. Respir. J., March 1, 2006; 27(3): 627 - 643. [Full Text] [PDF]

				K. R. Chapman, D. M. Mannino, J. B. Soriano, P. A. Vermeire, A. S. Buist, M. J. Thun, C. Connell, A. Jemal, T. A. Lee, M. Miravitlles, et al. Epidemiology and costs of chronic obstructive pulmonary disease Eur. Respir. J., January 1, 2006; 27(1): 188 - 207. [Full Text] [PDF]

				D D Sin, L Wu, J A Anderson, N R Anthonisen, A S Buist, P S Burge, P M Calverley, J E Connett, B Lindmark, R A Pauwels, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease Thorax, December 1, 2005; 60(12): 992 - 997. [Abstract] [Full Text] [PDF]

				F. Holguin, E. Folch, S. C. Redd, and D. M. Mannino Comorbidity and Mortality in COPD-Related Hospitalizations in the United States, 1979 to 2001 Chest, October 1, 2005; 128(4): 2005 - 2011. [Abstract] [Full Text] [PDF]

				D. Wilson, R. Adams, S. Appleton, R. Ruffin, and on behalf of the North West Adelaide (Cohort) Stud Difficulties Identifying and Targeting COPD and Population-Attributable Risk of Smoking for COPD: A Population Study Chest, October 1, 2005; 128(4): 2035 - 2042. [Abstract] [Full Text] [PDF]

				T. A. C. Nizet, F. J. J. van den Elshout, Y. F. Heijdra, M. J. T. van de Ven, P. G. H. Mulder, and H. Th. M. Folgering Survival of Chronic Hypercapnic COPD Patients Is Predicted by Smoking Habits, Comorbidity, and Hypoxemia Chest, June 1, 2005; 127(6): 1904 - 1910. [Abstract] [Full Text] [PDF]

				T. M. McKeever, S. A. Lewis, H. A. Smit, P. Burney, J. R. Britton, and P. A. Cassano The Association of Acetaminophen, Aspirin, and Ibuprofen with Respiratory Disease and Lung Function Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 966 - 971. [Abstract] [Full Text] [PDF]

				J. Dalstra, A. Kunst, C Borrell, E Breeze, E Cambois, G Costa, J. Geurts, E Lahelma, H Van Oyen, N. Rasmussen, et al. Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries Int. J. Epidemiol., April 1, 2005; 34(2): 316 - 326. [Abstract] [Full Text] [PDF]

				C. F. Simpson, N. M. Punjabi, L. Wolfenden, M. Shardell, D. M. Shade, and L. P. Fried Relationship Between Lung Function and Physical Performance in Disabled Older Women J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2005; 60(3): 350 - 354. [Abstract] [Full Text] [PDF]

				M. Lin, Y. Chen, and I. McDowell Increased risk of depression in COPD patients with higher education and income Chronic Respiratory Disease, January 1, 2005; 2(1): 13 - 19. [Abstract] [PDF]

				G. Viegi, G. Matteelli, A. Angino, A. Scognamiglio, S. Baldacci, J. B. Soriano, and L. Carrozzi The Proportional Venn Diagram of Obstructive Lung Disease in the Italian General Population Chest, October 1, 2004; 126(4): 1093 - 1101. [Abstract] [Full Text] [PDF]

				J. S. Rana, M. A. Mittleman, J. Sheikh, F. B. Hu, J. E. Manson, G. A. Colditz, F. E. Speizer, R. G. Barr, and C. A. Camargo Jr Chronic Obstructive Pulmonary Disease, Asthma, and Risk of Type 2 Diabetes in Women Diabetes Care, October 1, 2004; 27(10): 2478 - 2484. [Abstract] [Full Text] [PDF]

				P D Blanc, M D Eisner, L Trupin, E H Yelin, P P Katz, and J R Balmes The association between occupational factors and adverse health outcomes in chronic obstructive pulmonary disease Occup. Environ. Med., August 1, 2004; 61(8): 661 - 667. [Abstract] [Full Text] [PDF]

				B.R. Celli, W. MacNee, A. Agusti, A. Anzueto, B. Berg, A.S. Buist, P.M.A. Calverley, N. Chavannes, T. Dillard, B. Fahy, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur. Respir. J., June 1, 2004; 23(6): 932 - 946. [Full Text] [PDF]

				E. J. Silvertooth, P.M. Doraiswamy, G.L. Clary, M.A. Babyak, N. Wilkerson, C. Hellegars, and S.M. Palmer Citalopram and Quality of Life in Lung Transplant Recipients Psychosomatics, June 1, 2004; 45(3): 271 - 272. [Full Text] [PDF]

				N. Tzanakis, U. Anagnostopoulou, V. Filaditaki, P. Christaki, and N. Siafakas Prevalence of COPD in Greece Chest, March 1, 2004; 125(3): 892 - 900. [Abstract] [Full Text] [PDF]

				C M Roberts, S Barnes, D Lowe, and M G Pearson Evidence for a link between mortality in acute COPD and hospital type and resources Thorax, November 1, 2003; 58(11): 947 - 949. [Abstract] [Full Text] [PDF]

				I. Cerveri, S. Accordini, A. Corsico, M.C. Zoia, L. Carrozzi, L. Cazzoletti, M. Beccaria, A. Marinoni, G. Viegi, and R. de Marco Chronic cough and phlegm in young adults Eur. Respir. J., September 1, 2003; 22(3): 413 - 417. [Abstract] [Full Text] [PDF]

				L. Trupin, G. Earnest, M. San Pedro, J.R. Balmes, M.D. Eisner, E. Yelin, P.P. Katz, and P.D. Blanc The occupational burden of chronic obstructive pulmonary disease Eur. Respir. J., September 1, 2003; 22(3): 462 - 469. [Abstract] [Full Text] [PDF]

				The pharmacoepidemiology of COPD: Recent advances and methodological discussion Eur. Respir. J., September 1, 2003; 22(43_suppl): 1S - 44s. [Full Text] [PDF]

				N. Jakeways, T. McKeever, S.A. Lewis, S.T. Weiss, and J. Britton Relationship between FEV1 reduction and respiratory symptoms in the general population Eur. Respir. J., April 1, 2003; 21(4): 658 - 663. [Abstract] [Full Text] [PDF]

				S. Rennard, M. Decramer, P.M.A. Calverley, N.B. Pride, J.B. Soriano, P.A. Vermeire, and J. Vestbo Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey Eur. Respir. J., October 1, 2002; 20(4): 799 - 805. [Abstract] [Full Text] [PDF]